Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...

DBS analyst Nico Chen has maintained their bullish stance on LLY stock, giving a Buy rating on January 21.Invest with Confidence: Follow ...

Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...

The city of Greensboro has joined a national litigation campaign suing the nation's three largest pharmacy benefit managers and three largest insulin manufacturers with the goal of lowering insulin pr ...

City attorneys allege major Pharmacy Benefit Managers (PBMs) and insulin manufacturers are conspiring to artificially inflate ...

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

Massachusetts is the latest state going after insulin makers and the intermediaries officials accuse of price gouging. Why it ...

The city of Meriden, Connecticut, filed a lawsuit in federal court on Monday, accusing 20 companies, including major drug manufacturers such as CVS Health Corp., Eli Lilly and Co., and Novo Nordisk ...